Clinical Trial Update: Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients

View source ↗

Summary

A clinical trial evaluating a new reduced-intensity conditioning regimen of busulfan/fludarabine in older and/or intolerant patients with leukemia or myelodyspl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Leukemia, Myelodysplastic Syndrome | Status: UNKNOWN